252 related articles for article (PubMed ID: 10521479)
1. Differences in signaling properties of the cytoplasmic domains of the insulin receptor and insulin-like growth factor receptor in 3T3-L1 adipocytes.
Ursø B; Cope DL; Kalloo-Hosein HE; Hayward AC; Whitehead JP; O'Rahilly S; Siddle K
J Biol Chem; 1999 Oct; 274(43):30864-73. PubMed ID: 10521479
[TBL] [Abstract][Full Text] [Related]
2. Membrane localization of 3-phosphoinositide-dependent protein kinase-1 stimulates activities of Akt and atypical protein kinase C but does not stimulate glucose transport and glycogen synthesis in 3T3-L1 adipocytes.
Egawa K; Maegawa H; Shi K; Nakamura T; Obata T; Yoshizaki T; Morino K; Shimizu S; Nishio Y; Suzuki E; Kashiwagi A
J Biol Chem; 2002 Oct; 277(41):38863-9. PubMed ID: 12147684
[TBL] [Abstract][Full Text] [Related]
3. Increased insulin sensitivity in IGF-I receptor--deficient brown adipocytes.
Mur C; Valverde AM; Kahn CR; Benito M
Diabetes; 2002 Mar; 51(3):743-54. PubMed ID: 11872675
[TBL] [Abstract][Full Text] [Related]
4. Insulin receptor substrate 2 and Shc play different roles in insulin-like growth factor I signaling.
Kim B; Cheng HL; Margolis B; Feldman EL
J Biol Chem; 1998 Dec; 273(51):34543-50. PubMed ID: 9852124
[TBL] [Abstract][Full Text] [Related]
5. IRS-1 tyrosine phosphorylation reflects insulin-induced metabolic and mitogenic responses in 3T3-L1 pre-adipocytes.
Telting D; van der Zon GC; Dorrestijn J; Maassen JA
Arch Physiol Biochem; 2001 Feb; 109(1):52-62. PubMed ID: 11471071
[TBL] [Abstract][Full Text] [Related]
6. Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes.
Tremblay F; Gagnon A; Veilleux A; Sorisky A; Marette A
Endocrinology; 2005 Mar; 146(3):1328-37. PubMed ID: 15576463
[TBL] [Abstract][Full Text] [Related]
7. Chronic endothelin-1 treatment leads to heterologous desensitization of insulin signaling in 3T3-L1 adipocytes.
Ishibashi KI; Imamura T; Sharma PM; Huang J; Ugi S; Olefsky JM
J Clin Invest; 2001 May; 107(9):1193-202. PubMed ID: 11342583
[TBL] [Abstract][Full Text] [Related]
8. Essential role of insulin receptor substrate-2 in insulin stimulation of Glut4 translocation and glucose uptake in brown adipocytes.
Fasshauer M; Klein J; Ueki K; Kriauciunas KM; Benito M; White MF; Kahn CR
J Biol Chem; 2000 Aug; 275(33):25494-501. PubMed ID: 10829031
[TBL] [Abstract][Full Text] [Related]
9. Insulin receptor substrate (IRS) proteins IRS-1 and IRS-2 differential signaling in the insulin/insulin-like growth factor-I pathways in fetal brown adipocytes.
Valverde AM; Lorenzo M; Pons S; White MF; Benito M
Mol Endocrinol; 1998 May; 12(5):688-97. PubMed ID: 9605931
[TBL] [Abstract][Full Text] [Related]
10. Mechanism for differential effect of protein-tyrosine phosphatase 1B on Akt versus mitogen-activated protein kinase in 3T3-L1 adipocytes.
Shimizu S; Maegawa H; Egawa K; Shi K; Bryer-Ash M; Kashiwagi A
Endocrinology; 2002 Dec; 143(12):4563-9. PubMed ID: 12446583
[TBL] [Abstract][Full Text] [Related]
11. Tyrosine phosphorylation-dependent and -independent role of Shc in the regulation of IGF-1-induced mitogenesis and glycogen synthesis.
Sasaoka T; Ishiki M; Wada T; Hori H; Hirai H; Haruta T; Ishihara H; Kobayashi M
Endocrinology; 2001 Dec; 142(12):5226-35. PubMed ID: 11713219
[TBL] [Abstract][Full Text] [Related]
12. Cholesterol depletion disrupts caveolae and insulin receptor signaling for metabolic control via insulin receptor substrate-1, but not for mitogen-activated protein kinase control.
Parpal S; Karlsson M; Thorn H; Strålfors P
J Biol Chem; 2001 Mar; 276(13):9670-8. PubMed ID: 11121405
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of SH2-containing inositol phosphatase 2 results in negative regulation of insulin-induced metabolic actions in 3T3-L1 adipocytes via its 5'-phosphatase catalytic activity.
Wada T; Sasaoka T; Funaki M; Hori H; Murakami S; Ishiki M; Haruta T; Asano T; Ogawa W; Ishihara H; Kobayashi M
Mol Cell Biol; 2001 Mar; 21(5):1633-46. PubMed ID: 11238900
[TBL] [Abstract][Full Text] [Related]
14. Involvement of the actin network in insulin signalling.
Tsakiridis T; Wang Q; Taha C; Grinstein S; Downey G; Klip A
Soc Gen Physiol Ser; 1997; 52():257-71. PubMed ID: 9210235
[TBL] [Abstract][Full Text] [Related]
15. Platelet-derived growth factor (PDGF) stimulates glucose transport in 3T3-L1 adipocytes overexpressing PDGF receptor by a pathway independent of insulin receptor substrates.
Whiteman EL; Chen JJ; Birnbaum MJ
Endocrinology; 2003 Sep; 144(9):3811-20. PubMed ID: 12933652
[TBL] [Abstract][Full Text] [Related]
16. Adapter protein with a pleckstrin homology (PH) and an Src homology 2 (SH2) domain (APS) and SH2-B enhance insulin-receptor autophosphorylation, extracellular-signal-regulated kinase and phosphoinositide 3-kinase-dependent signalling.
Ahmed Z; Pillay TS
Biochem J; 2003 Apr; 371(Pt 2):405-12. PubMed ID: 12521378
[TBL] [Abstract][Full Text] [Related]
17. Intracellular localization of phosphatidylinositide 3-kinase and insulin receptor substrate-1 in adipocytes: potential involvement of a membrane skeleton.
Clark SF; Martin S; Carozzi AJ; Hill MM; James DE
J Cell Biol; 1998 Mar; 140(5):1211-25. PubMed ID: 9490733
[TBL] [Abstract][Full Text] [Related]
18. Ret oncogene signal transduction via a IRS-2/PI 3-kinase/PKB and a SHC/Grb-2 dependent pathway: possible implication for transforming activity in NIH3T3 cells.
Hennige AM; Lammers R; Arlt D; Höppner W; Strack V; Niederfellner G; Seif FJ; Häring HU; Kellerer M
Mol Cell Endocrinol; 2000 Sep; 167(1-2):69-76. PubMed ID: 11000521
[TBL] [Abstract][Full Text] [Related]
19. Engagement of the insulin-sensitive pathway in the stimulation of glucose transport by alpha-lipoic acid in 3T3-L1 adipocytes.
Yaworsky K; Somwar R; Ramlal T; Tritschler HJ; Klip A
Diabetologia; 2000 Mar; 43(3):294-303. PubMed ID: 10768090
[TBL] [Abstract][Full Text] [Related]
20. Dexamethasone-induced insulin resistance in 3T3-L1 adipocytes is due to inhibition of glucose transport rather than insulin signal transduction.
Sakoda H; Ogihara T; Anai M; Funaki M; Inukai K; Katagiri H; Fukushima Y; Onishi Y; Ono H; Fujishiro M; Kikuchi M; Oka Y; Asano T
Diabetes; 2000 Oct; 49(10):1700-8. PubMed ID: 11016454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
